Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.42 |
| ▸ | KDM1A | O60341 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4652712 | 0.91 | ALDH1A1 (0.41) | ALDH1A1GAAMAPTSIGMAR1KDM1A | |
| SCHEMBL562899 | 0.85 | KDM1A (0.42) | ALDH1A1GAASIGMAR1KDM1AHTR2A | |
| SCHEMBL1812009 | 0.82 | TSHR (0.45) | TSHRNPSR1ANPEP | |
| SCHEMBL24650850 | 0.80 | CYP3A4 (0.38) | ALDH1A1KDM1ATSHR | |
| SCHEMBL7891735 | 0.79 | MEN1 (0.44) | ALDH1A1GAAMAPTTSHRNPSR1 | |
| SCHEMBL7891742 | 0.79 | MEN1 (0.44) | ALDH1A1GAAMAPTTSHRNPSR1 | |
| SCHEMBL8045772 | 0.79 | ALDH1A1 (0.41) | ALDH1A1GAAMAPTTSHRNPSR1 | |
| SCHEMBL3327022 | 0.79 | ALDH1A1 (0.41) | ALDH1A1GAAMAPTTSHRNPSR1 | |
| SCHEMBL8410178 | 0.79 | ALDH1A1 (0.41) | ALDH1A1GAAMAPTTSHRNPSR1 | |
| SCHEMBL7891740 | 0.79 | MEN1 (0.44) | ALDH1A1GAAMAPTTSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022238507-A1 | THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS | AWAKN LS EUROPE HOLDINGS LIMITED (IE) | 2022-11-17 | — | — | WO | disclosed |
| WO-2014202993-A1 | BINDING MOTIF FOR THROMBIN INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2014-12-24 | — | — | WO | disclosed |
| CN-101108878-B | Glp-1 analogues | SOD CONSEILS RECH APPLIC | 2012-08-29 | — | — | CN | disclosed |
| CN-1935839-B | Analogues of GLP-1 | IPSEN PHARMA SAS (FR) | 2012-06-06 | — | — | CN | disclosed |
| US-20120045393-A1 | LHRH-II PEPTIDE ANALOGS | BRACCO IMAGING SPA (IT) | 2012-02-23 | — | — | US | disclosed |
| WO-2009144432-A1 | MC4-R AGONISTS FOR THE TREATMENT OF OBESITY | PALATIN TECHNOLOGIES, INC. (US) | 2009-12-03 | — | — | WO | disclosed |
| CN-100540566-C | Glucagon-like peptide-1 analogs | SOD CONSEILS RECH APPLIC (FR) | 2009-09-16 | — | — | CN | disclosed |
| US-7550602-B1 | Small molecule compositions for sexual dysfunction | PALATIN TECHNOLOGIES, INC. (US) | 2009-06-23 | — | — | US | disclosed |
| US-7456184-B2 | Melanocortin receptor-specific compounds | PALATIN TECHNOLOGIES INC. (US) | 2008-11-25 | — | — | US | disclosed |
| EP-1622618-A4 | MELANOCORTIN RECEPTOR-SPECIFIC COMPOUNDS | PALATIN TECHNOLOGIES INC (US) | 2008-08-27 | — | — | EP | disclosed |
| CN-1342166-A | Glucagon-like peptide-1 analogs | SOD CONSEILS RECH APPLIC (FR) | 2002-03-27 | — | — | CN | disclosed |
| CN-1329620-A | Glucagon-like peptide-1 analogs | CONSEILS DE RECH SET D APPLIC (FR) | 2002-01-02 | — | — | CN | disclosed |
| EP-0649434-B1 | RADIOACTIVELY-LABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATIDE INC (US) | 2001-08-01 | — | — | EP | disclosed |
| EP-1094074-A2 | Radioactively-labeled somatostatin derived peptides for imaging and therapeutic uses | Diatide, Inc. (US) | 2001-04-25 | — | — | EP | disclosed |
| US-6207643-B1 | PSEUDOPEPTIDE ANALOGS ARE PRODUCED WHICH EXHIBIT AN OVERALL AMPHIPHILIC NATURE AND WHICH ARE CAPABLE OF PENETRATING THE INSECT CUTICLE WHILE STILL RETAINING BIOLOGICAL ACTIVITY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2001-03-27 | — | — | US | disclosed |
| WO-2000029010-A1 | MIMETIC INSECT ALLATOSTATIN ANALOGS FOR INSECT CONTROL | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2000-05-25 | — | — | WO | disclosed |
| CN-1232038-A | New peptide compounds, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1999-10-20 | — | — | CN | disclosed |
| US-5871711-A | MEDICAL DIAGNOSIS LABELED WITH TECHNETIUM FOR PEPTIDES | DIATIDE, INC. (US) | 1999-02-16 | — | — | US | disclosed |
| EP-0649434-A1 | RADIOACTIVELY-LABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | Diatide, Inc. (US) | 1995-04-26 | — | — | EP | disclosed |
| WO-1994000489-A2 | RADIOACTIVELY-LABELED SOMATOSTANTIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATECH, INC. (US) | 1994-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120045393-A1 | LHRH-II PEPTIDE ANALOGS | LHCGR, GNRHR, FSHR | ALDH1A1 4273/4885GAA 1399/4885MAPT 2988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.